Clinical Trial Update: Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab and lenvatinib after definitive chemoradiation in locally advanced head and neck squamous cell carcinoma is active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Universität des Saarlandes | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING